Stevanato Group SpA
NYSE:STVN
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
16.93
34.28
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Stevanato Group SpA
Stevanato Group SpA
Cash Equivalents
Stevanato Group SpA
Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Stevanato Group SpA
NYSE:STVN
|
Cash Equivalents
€69.6m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Fine Foods & Pharmaceuticals NTM SpA
MIL:FF
|
Cash Equivalents
€15.2m
|
CAGR 3-Years
49%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Stevanato Group SpA
Glance View
Stevanato Group SpA, a stalwart in the realm of pharmaceutical and healthcare solutions, has carved its niche as a pioneering force in precision glass packaging and integrated drug delivery systems. founded in 1949 in Italy, the company ingeniously combines its deep-rooted expertise in glass manufacturing with cutting-edge technology to meet the burgeoning demands of the healthcare and pharmaceutical sectors. Stevanato’s operations are deftly structured around two main segments: the pharmaceutical systems division and the engineering division. Through its pharmaceutical systems division, the company crafts highly specialized glass vials, syringes, and cartridges critical for ensuring the safety and efficacy of drug delivery. These glass containers are not mere vessels but are integral to preserving the integrity of high-value biologic drugs, a prerequisite for gaining regulatory approval and market success. Reaping the benefits of a vertically integrated business model, Stevanato’s engineering division complements its offerings by designing, developing, and manufacturing machinery and technology that optimize the production and inspection of its glass products. This segment caters to pharmaceutical companies' needs for enhanced reliability and efficiency in manufacturing processes, enabling Stevanato to cover the entire value chain from raw material sourcing to final packaging inspection. This seamless integration not only fortifies the company's market position but also ensures a robust revenue stream from both products and services. Stevanato Group's commitment to innovation and quality control, coupled with strategic collaborations, have propelled it as an indispensable partner to global pharmaceutical giants, anchoring its role as both a defender of drug integrity and a trailblazer in medical glassware innovation.
See Also
What is Stevanato Group SpA's Cash Equivalents?
Cash Equivalents
69.6m
EUR
Based on the financial report for Dec 31, 2023, Stevanato Group SpA's Cash Equivalents amounts to 69.6m EUR.
What is Stevanato Group SpA's Cash Equivalents growth rate?
Cash Equivalents CAGR 3Y
-16%
Over the last year, the Cash Equivalents growth was -70%. The average annual Cash Equivalents growth rates for Stevanato Group SpA have been -16% over the past three years .
You don't have any saved screeners yet
